Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy

British Journal of Anaesthesia

Volumn 113, Issue 4, 2014, Pages 628-633

  Adelmann, D ^a   Klaus, D A ^a   Illievich, U M ^b   Krenn, C G ^a   Krall, C ^a   Kozek Langenecker, S ^c   Schaden, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c Evangelical Hospital Vienna   (Austria)

Author keywords

Blood coagulation disorders; Blood coagulation tests; Complications; Factor XIII; Fibrinogen; Haemorrhage; Neurosurgery; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FIBRINOGEN CONCENTRATE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CRANIOTOMY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FIBRINOGEN DEFECT; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; AFIBRINOGENEMIA; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD COAGULATION DISORDERS, SURGERY; CONFIDENCE INTERVAL; METABOLISM; MIDDLE AGED; NEUROSURGERY; NEUROSURGERY, COMPLICATIONS; PARTIAL THROMBOPLASTIN TIME; RECEIVER OPERATING CHARACTERISTIC; RISK; THROMBOCYTE COUNT; VERY ELDERLY; YOUNG ADULT;

BLOOD COAGULATION DISORDERS, SURGERY; BLOOD COAGULATION TESTS; FACTOR XIII; FIBRINOGEN; HAEMORRHAGE; NEUROSURGERY, COMPLICATIONS;

ADOLESCENT; ADULT; AFIBRINOGENEMIA; AGED; AGED, 80 AND OVER; BLOOD COAGULATION TESTS; COAGULATION PROTEIN DISORDERS; CONFIDENCE INTERVALS; CRANIOTOMY; FACTOR XIII; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; ODDS RATIO; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84904062361     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu133     Document Type: Article

References (20)

1. Seifman MA, Lewis PM, Rosenfeld JV, Hwang PYK. Postoperative intracranial haemorrhage: a review. Neurosurg Rev 2011; 34: 393-407
2. Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93: 327-58
3. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21
4. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronaryartery bypass grafting surgery: aprospective observational study. Transfusion 2008; 48: 2152-8
5. Carling MS, Jeppsson A, Wessberg P, Henriksson A, Baghaei F, Brisby H. Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in scoliosis surgery. Spine 2011; 36: 549-55
6. Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-23
7. Idris Z, Muzaimi M, Hussin S, Mahmood WHW, Abdullah WZ. Association of perioperative factor XIII activity levels and other haemostatic markers with the risk of postoperative intracranial haematoma in a selected cohort of neurosurgical patients. Acta Neurochir 2012; 154: 887-94
8. Levey AS, Greene T, Schluchter MD, et al. Glomerular filtration rate measurements in clinical trials. Am Soc Nephrol 1993; 4: 1159-71
9. Gross JB Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983; 58: 277-80
10. Lison S, Weiss G, Spannagl M, Heindl B. Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 2011; 22: 190-6
11. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76
12. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding. Eur J Anaesthesiol 2013; 30: 270-382
13. Kozek-Langenecker S, Sørensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15: R239
14. Korte WC, Szadkowski C, Gähler A, et al. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110: 239-45
15. Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33
16. Dützmann S, Gessler F, Marquardt G, Seifert V, Senft C. On the value of routine prothrombin time screening in elective neurosurgical procedures. Neurosurg Focus 2012; 33: E9
17. Koscielny J, Sabine Z, Radtke H, et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 195-204
18. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost 2009; 35: 426-38
19. Alhomsi K. Evaluation of a New, Automated Quantitative Factor XIII Assay. Available from http://us.instrumentationlaboratory.com/~/media/IL/Docs/Product/Hemostasis/Scientific%20Publications/Alhomsi%20FINAL.pdf (accessed 10 September 2013)
20. Lassen B, Helseth E, Rønning P, et al. Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors. Neurosurgery 2011; 68: 1259-69